{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:17:01Z","timestamp":1785860221027,"version":"3.56.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Phenylketonuria (PKU) is an inborn error of metabolism caused by a deficiency of the enzyme phenylalanine hydroxylase. If untreated, the complications of PKU lead to significant neucognitive and neuropsychiatric impairments, placing a burden on both the individual\u2019s quality of life and on the healthcare system. We conducted a systematic literature review to characterize the impact of PKU on affected individuals and on healthcare resources in Latin American (LATAM) countries.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Searches of the global medical literature as well as regional and local medical literature up to September 2021. Observational studies on patients with PKU from any LATAM country. Pairs of reviewers independently screened eligible articles, extracted data from included studies, and assessed their risk of bias.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>79 unique studies (47 cross-sectional studies, 18 case series, 12 case reports, and two cohort studies) with a total of 4090 patients were eligible. Of these studies, 20 had data available evaluating early-diagnosed PKU patients for meta-analysis of burden outcomes. Intellectual disability in the pooled studies was 18% [95% Confidence Interval (CI) 0.04\u20130.38; I<jats:sup>2<\/jats:sup>\u2009=\u200983.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0133; two studies; n\u2009=\u2009114]. Motor delay was 15% [95% CI 0.04\u20130.30; I<jats:sup>2<\/jats:sup>\u2009=\u200974.5%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0083; four studies; n\u2009=\u2009132]. Speech deficit was 35% [95% CI 0.08\u20130.68; I<jats:sup>2<\/jats:sup>\u2009=\u200993.9%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001; five studies; n\u2009=\u2009162].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>There is currently evidence of high clinical burden in PKU patients in LATAM countries. Recognition that there are many unmet neuropsychological needs and socioeconomic challenges faced in the LATAM countries is the first step in planning cost-effective interventions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02450-2","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T09:02:52Z","timestamp":1659171772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Burden of phenylketonuria in Latin American patients: a systematic review and meta-analysis of observational studies"],"prefix":"10.1186","volume":"17","author":[{"given":"A. L. S.","family":"Pessoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Specola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vilela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Jurecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Mesojedovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7933-6687","authenticated-orcid":false,"given":"I. V. D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"issue":"2","key":"2450_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2013.157","volume":"16","author":"J Vockley","year":"2014","unstructured":"Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16(2):188\u2013200.","journal-title":"Genet Med"},{"issue":"6","key":"2450_CR2","first-page":"279","volume":"33","author":"JCG Borrajo","year":"2012","unstructured":"Borrajo JCG. Panorama epidemiol\u00f3gico de la fenilcetonuria (PKU) en Latinoam\u00e9rica. Acta Pediatr Mex. 2012;33(6):279\u201387.","journal-title":"Acta Pediatr Mex"},{"issue":"1","key":"2450_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2450_CR4","first-page":"31","volume":"29","author":"RA Williams","year":"2008","unstructured":"Williams RA, Mamotte CD, Burnett JR. Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev. 2008;29(1):31\u201341.","journal-title":"Clin Biochem Rev"},{"issue":"4","key":"2450_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s10545-007-0669-9","volume":"30","author":"GJ Borrajo","year":"2007","unstructured":"Borrajo GJ. Newborn screening in Latin America at the beginning of the 21st century. J Inherit Metab Dis. 2007;30(4):466\u201381.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2450_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/ajmg.c.31899","volume":"187","author":"GJC Borrajo","year":"2021","unstructured":"Borrajo GJC. Newborn screening in Latin America: a brief overview of the state of the art. Am J Med Genet C Semin Med Genet. 2021;187(3):322\u20138.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"8","key":"2450_CR7","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3390\/nu13082566","volume":"13","author":"S Poloni","year":"2021","unstructured":"Poloni S, Dos Santos BB, Chiesa A, Specola N, Pereyra M, Saborio-Rocafort M, et al. Current practices and challenges in the diagnosis and management of PKU in Latin America: a multicenter survey. Nutrients. 2021;13(8):2566.","journal-title":"Nutrients"},{"issue":"15","key":"2450_CR8","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"issue":"9","key":"2450_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","volume":"5","author":"FJ van Spronsen","year":"2017","unstructured":"van Spronsen FJ, van Wegberg AM, Ahring K, B\u00e9langer-Quintana A, Blau N, Bosch AM, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743\u201356.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2450_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1464-410X.2011.10885.x","volume":"110","author":"R El Dib","year":"2012","unstructured":"El Dib R, Touma NJ, Kapoor A. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU Int. 2012;110(4):510\u20136.","journal-title":"BJU Int"},{"issue":"12","key":"2450_CR11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1590\/S0102-86502013001200010","volume":"28","author":"R El Dib","year":"2013","unstructured":"El Dib R, Nascimento Junior P, Kapoor A. An alternative approach to deal with the absence of clinical trials: a proportional meta-analysis of case series studies. Acta Cir Bras. 2013;28(12):870\u20136.","journal-title":"Acta Cir Bras"},{"issue":"3","key":"2450_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"12","key":"2450_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011458","volume":"6","author":"MJ Downes","year":"2016","unstructured":"Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6(12): e011458.","journal-title":"BMJ Open"},{"key":"2450_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1590\/S0103-05822011000400022","volume":"29","author":"T Amorim","year":"2011","unstructured":"Amorim T, Boa-Sorte N, Leite MEQ, Acosta AX. Aspectos cl\u00ednicos e demogr\u00e1ficos da fenilceton\u00faria no Estado da Bahia. Revista Paulista de Pediatria. 2011;29:612\u20137.","journal-title":"Revista Paulista de Pediatria"},{"key":"2450_CR15","unstructured":"Azcoiti ME, Chiesa A, R. E, Valle G, Mendez V, Gotta G, et al. Implementation of molecular diagnosis for PAH related disorders in a public hospital. Annual Meeting of Bioscience Societes 2020; 10\u201313 November 2020. MEDICINA2020."},{"issue":"4","key":"2450_CR16","first-page":"332","volume":"55","author":"EV Cornejo","year":"2005","unstructured":"Cornejo EV, Concha M, Cabello JF, Raimann E. Lipids composition diet in phenylketonuric children with early diagnosis. Arch Latinoam Nutr. 2005;55(4):332\u20135.","journal-title":"Arch Latinoam Nutr"},{"key":"2450_CR17","unstructured":"Keselman A, Cassinelli H, Fraga C, Gru\u00f1eiro-Papendieck L, Chiesa A. Bone mineral density (BMD) and phenylketonuria (PKU). 7th Joint Meeting Paediatric Endocrinology in collaboration with APEG, APPES, JSPE and SLEP; Lyon, France 2005."},{"key":"2450_CR18","doi-asserted-by":"crossref","unstructured":"Fraga C, Valle MG, Enacan R, Chiesa A. Bone Mineral Density and BH4 Treatment. 13th International Congress of Inborn Errors of Metabolism; 5\u20138 September 2017; Rio de Janeiro, Brazil: J Inborn Errors Metab Screen; 2017. p. 1\u2013413.","DOI":"10.1177\/2326409817730396"},{"issue":"2","key":"2450_CR19","first-page":"20","volume":"7","author":"AB Mendes","year":"2006","unstructured":"Mendes AB. Fragilidade \u00d3ssea dos Fenilceton\u00faricos, Reflexo da Dietoterapia? \u2013 Um estudo com pacientes da APAE-RIO. Revista de Pediatria SOPERJ. 2006;7(2):20.","journal-title":"Revista de Pediatria SOPERJ"},{"key":"2450_CR20","unstructured":"Cerqueira MMM. O engajamento dos cuidadores na dieta para as suas crian\u00e7as fenilceton\u00faricas: influ\u00eancia de fatores s\u00f3cio-demogr\u00e1ficos e psicossociais: Universidade Federal de Minas Gerais \u2013 Minas Gerais; 2004."},{"key":"2450_CR21","unstructured":"Dutra VF. Avalia\u00e7\u00e3o neuropsicol\u00f3gica de crian\u00e7as e adolescentes com hiperfenilalaninemias: Faculdade de Ci\u00eancias M\u00e9dicas da Universidade de Campinas - S\u00e3o Paulo; 2013."},{"key":"2450_CR22","unstructured":"Figueira VB. Perfil cl\u00ednico e epidemiol\u00f3gico de pacientes portadores de fenilceton\u00faria no estado de Goi\u00e1s: Universidade Federal de Goi\u00e1s \u2013 Goi\u00e1s; 2018."},{"key":"2450_CR23","unstructured":"Martins FF. Efeito do consumo de biscoitos enriquecidos com c\u00e1lcio em pacientes com fenilceton\u00faria: Universidade Federal Fluminense \u2013 Rio de Janeiro; 2007."},{"key":"2450_CR24","unstructured":"Mor\u00e3o CPAB. Perfil neuropsicol\u00f3gico e desempenho executivo de crian\u00e7as com fenilceton\u00faria tratada: Universidade Presbiteriana Mackenzie; 2017."},{"key":"2450_CR25","unstructured":"Oliveira RF. Condi\u00e7\u00f6es de sa\u00fade dental e gengival em crian\u00e7as com fenilceton\u00faria atendidas na Funda\u00e7\u00e4o Ecum\u00eanica de Prote\u00e7\u00e4o ao Excepcional (FEPE) no Estado do Paran\u00e1 2001."},{"key":"2450_CR26","unstructured":"Sena BS. Estado nutricional e indicadores antropom\u00e9tricos de risco cardiovascular de pacientes com diagn\u00f3tico de fenilceton\u00faria atendidos em um servi\u00e7o de refer\u00eancia do nordeste brasileiro: Universidade Federal de Pernambuco \u2013Pernambuco; 2018."},{"key":"2450_CR27","unstructured":"Silva GK. Habilidades do comportamento comunicativo de crian\u00e7as com fenilceton\u00faria tratadas desde o per\u00edodo neonatal: Faculdade de Odontologia de Bauru da Universidade de S\u00e3o Paulo \u2013S\u00e3o Paulo; 2008."},{"key":"2450_CR28","unstructured":"Starling ALP. Densitometria \u00f3ssea em crian\u00e7as e adolescentes fenilceton\u00faricos: Universidade Federal de Minas Gerais \u2013 Minas Gerais; 2005."},{"key":"2450_CR29","unstructured":"Vieira TA. Fatores associados a ades\u00e3o ao tratamento dos pacientes com fenilceton\u00faria acompanhados pelo servi\u00e7o de gen\u00e9tica m\u00e9dica do hospital de cl\u00ednicas de Porto Alegre: Universidade Federal do Rio Grande do Sul \u2013 Rio Grande do Sul; 2010."},{"key":"2450_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2020.100624","volume":"24","author":"AM Martins","year":"2020","unstructured":"Martins AM, Pessoa ALS, Quesada AA, Ribeiro EM. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: results from a survey with 228 patients and their caregivers. Mol Genet Metab Rep. 2020;24: 100624.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"2450_CR31","first-page":"93","volume":"14","author":"MT Beckhauser","year":"2020","unstructured":"Beckhauser MT, Beghini Mendes Vieira M, Moehlecke Iser B, Rozone DELG, Rodrigues Masruha M, Lin J, et al. Attention deficit disorder with hyperactivity symptoms in early-treated phenylketonuria patients. Iran J Child Neurol. 2020;14(1):93\u2013103.","journal-title":"Iran J Child Neurol"},{"key":"2450_CR32","first-page":"293","volume":"72","author":"V Ben\u00edtez","year":"2001","unstructured":"Ben\u00edtez V, San Juli\u00e1n E, Rodr\u00edguez MM. Fenilcetonuria: a prop\u00f3sito de dos pacientes. Arch Pediatr Urug. 2001;72:293\u20137.","journal-title":"Arch Pediatr Urug"},{"key":"2450_CR33","doi-asserted-by":"crossref","unstructured":"Bernal AC, Eiroa H. Fenilcetonuria de diagnostico tardio. Sociedad Iberoamericana de Informaci\u00f3n Cient\u00edfica (SIIC). 2017.","DOI":"10.21840\/siic\/153738"},{"issue":"5","key":"2450_CR34","first-page":"1658","volume":"27","author":"FA Blanco","year":"2012","unstructured":"Blanco FA, Quintana AB, Martinez CV, Pardo MM. Importance of early diagnosis of phenylketonuria in women and control of phenylalanine levels during pregnancy. Nutr Hosp. 2012;27(5):1658\u201361.","journal-title":"Nutr Hosp"},{"key":"2450_CR35","doi-asserted-by":"publisher","DOI":"10.1590\/2326-4594-JIEMS-2020-0014","author":"ML Pardo-Campos","year":"2021","unstructured":"Pardo-Campos ML, Enacan R, Valle MG, Chiesa A. Parenting styles and coping strategies in PKU early detected children. J Inborn Errors Metab Screen. 2021. https:\/\/doi.org\/10.1590\/2326-4594-jiems-2020-0014.","journal-title":"J Inborn Errors Metab Screen."},{"key":"2450_CR36","unstructured":"Pardo-Campos ML, Enacan R, Valle MG, Chiesa A. Parenting styles and coping strategies in PKU children 11th Congress of the Latin American Society of Inborn Errors of Metabolism and Neonatal Screening; 12\u201315 May 2019; Buenos Aires: J Inborn Errors Metab Screen; 2019."},{"key":"2450_CR37","unstructured":"Pardo-Campos ML, Enacan R, Valle MG, Chiesa A. Cognitive asssessment of early detected and treated PKU children. 11th Congress of the Latin American Society of Inborn Errors of Metabolism and Neonatal Screening; 12\u201315 May 2019; Buenos Aires: J Inborn Errors Metab Screen; 2019."},{"issue":"6","key":"2450_CR38","first-page":"308","volume":"33","author":"A Chiesa","year":"2012","unstructured":"Chiesa A, Fraga C, Prieto L, Pardo ML. Modelo de atenci\u00f3n de pacientes con fenilcetonuria (PKU) en Argentina. Acta Pedi\u00e1trica de M\u00e9xico. 2012;33(6):308\u201310.","journal-title":"Acta Pedi\u00e1trica de M\u00e9xico"},{"issue":"4","key":"2450_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4067\/S0370-41061988000400001","volume":"59","author":"MC Colombo","year":"1988","unstructured":"Colombo MC, Troncoso L, Raimann E, Perates CG, Barros T, Cornejo V. Diagnostico de fenilquetonuria en Chile. Rev Chil Pediatr. 1988;59(4):235\u20139.","journal-title":"Rev Chil Pediatr"},{"issue":"6","key":"2450_CR40","first-page":"301","volume":"33","author":"EV Cornejo","year":"2012","unstructured":"Cornejo EV, Castro G, Fern\u00e1ndez E, Cabello JF, Raimann E, De la Parra APS, et al. Modelo chileno de seguimiento a largo plazo para fenilcetonuria (PKU). Acta Pediatr Mex. 2012;33(6):301\u20137.","journal-title":"Acta Pediatr Mex"},{"key":"2450_CR41","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.4067\/S0034-98872003001100008","volume":"131","author":"EV Cornejo","year":"2003","unstructured":"Cornejo EV, Manr\u00edquez EV, Colombo CM, Mabe SP, Jim\u00e9nez MM, De la Parra CA, et al. Fenilquetonuria de diagn\u00f3stico neonatal y lactancia materna. Rev Med Chile. 2003;131:1280\u20137.","journal-title":"Rev Med Chile"},{"key":"2450_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4067\/S0370-41061995000600002","volume":"66","author":"EV Cornejo","year":"1995","unstructured":"Cornejo EV, Raimann BE, Godoy PX, Colombo CM. Seguimiento de pacientes con hiperfenilalaninemia diagnosticados precozmente. Rev Chil Pediatr. 1995;66:300\u20133.","journal-title":"Rev Chil Pediatr"},{"issue":"4","key":"2450_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s13760-018-0972-2","volume":"120","author":"FGS da Silva","year":"2020","unstructured":"da Silva FGS, de Souza CFM, Schwartz IVD. Attention-deficit hyperactivity disorder in Brazilian patients with phenylketonuria. Acta Neurol Belg. 2020;120(4):893\u20139.","journal-title":"Acta Neurol Belg"},{"key":"2450_CR44","first-page":"274","volume":"58","author":"M De Lucca","year":"2017","unstructured":"De Lucca M, Barba-Guzm\u00e1n C, Cobo-Sevilla V, Latta MA. Fenilcetonuria de diagn\u00f3stico tard\u00edo y mutaciones asociadas en una familia ecuatoriana. Invest Clin. 2017;58:274\u201383.","journal-title":"Invest Clin"},{"key":"2450_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0004-282X1967000100001","volume":"25","author":"AJ Diament","year":"1967","unstructured":"Diament AJ, Lef\u00e8vre AB. Fenilceton\u00faria: estudo cl\u00ednico e mediante bi\u00f3psia cerebral. Arq Neuropsiquiatr. 1967;25:1\u201316.","journal-title":"Arq Neuropsiquiatr"},{"key":"2450_CR46","doi-asserted-by":"crossref","unstructured":"Enac\u00e1n R, Prieto L, Nu\u00f1ez-Mi\u00f1ana M, Fernandez L, Valle MG, Salerno M, et al. Phenylalanine hydroxilase (PAH) genotyping in PKU argentine patients. Congreso Latinoamericano de Erroes Innatos del Metabolismo y Pesquisa Neonatal; 12\u201315 May 2019; Buenos Aires. J Inborn Errors Metab Screen. 2019.","DOI":"10.1590\/2326-4594-jiems-2019-0012"},{"key":"2450_CR47","doi-asserted-by":"publisher","DOI":"10.1590\/2326-4594-JIEMS-2019-0012","author":"R Enac\u00e1n","year":"2019","unstructured":"Enac\u00e1n R, Mi\u00f1ana MN, Fernandez L, Valle MG, Salerno M, Fraga CI, et al. Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients. J Inborn Errors Metab Screen. 2019. https:\/\/doi.org\/10.1590\/2326-4594-jiems-2019-0012.","journal-title":"J Inborn Errors Metab Screen"},{"key":"2450_CR48","first-page":"36","volume":"17","author":"M Escaf","year":"2003","unstructured":"Escaf M. Fenilcetonuria e hiperfenilalaninemia en reci\u00e9n nacidos. Salud Uninorte. 2003;17:36\u20139.","journal-title":"Salud Uninorte"},{"key":"2450_CR49","first-page":"99","volume":"12","author":"MTC Esteves","year":"1990","unstructured":"Esteves MTC, Chagas ACR, Vignoli VV, Castilho OB. Incid\u00eancia de fenilceton\u00faria em pacientes com retardamento mental em Alfenas, Minas Gerais. Rev Esc Farm Odontol Alfenas. 1990;12:99\u2013107.","journal-title":"Rev Esc Farm Odontol Alfenas"},{"issue":"1","key":"2450_CR50","first-page":"70","volume":"32","author":"D Fagioli","year":"2014","unstructured":"Fagioli D, Coelho HDS, Maturana N, Almeida EC, Marques T, Masson IB. Pr\u00e1ticas alimentares nos primeiros seis meses de vida de crian\u00e7as com Fenilceton\u00faria. J Health Sci Inst. 2014;32(1):70\u20133.","journal-title":"J Health Sci Inst"},{"issue":"10","key":"2450_CR51","first-page":"813","volume":"26","author":"EA Figueir\u00f3-Filho","year":"2004","unstructured":"Figueir\u00f3-Filho EA, Lopes AHA, Senefonte FRA, J\u00fanior VGS, Botelho CA, Duarte G. Maternal phenylketonuria: a case report. Rev Bras Ginecol Obstet. 2004;26(10):813\u20137.","journal-title":"Rev Bras Ginecol Obstet"},{"key":"2450_CR52","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1590\/S1516-31801999000500002","volume":"117","author":"RM Fisberg","year":"1999","unstructured":"Fisberg RM, Silva-Fernandes ME, Schmidt BJ, Fisberg M. Nutritional evaluation of children with phenylketonuria. Sao Paulo Med J. 1999;117:185\u201391.","journal-title":"Sao Paulo Med J"},{"key":"2450_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1590\/S1678-77572009000700012","volume":"17","author":"MG Gej\u00e3o","year":"2009","unstructured":"Gej\u00e3o MG, Ferreira AT, Silva GK, Anast\u00e1cio-Pessan FL, Lam\u00f4nica DAC. Communicative and psycholinguistic abilities in children with phenylketonuria and congenital hypothyroidism. J Appl Oral Sci. 2009;17:69\u201375.","journal-title":"J Appl Oral Sci"},{"issue":"3","key":"2450_CR54","first-page":"390","volume":"36","author":"N Gelvez","year":"2016","unstructured":"Gelvez N, Acosta J, Lopez G, Castro D, Prieto JC, Bermudez M, et al. Phenotypic and molecular characterization of a Colombian family with phenylketonuria. Biomedica Revista del Instituto Nacional de Salud. 2016;36(3):390\u20136.","journal-title":"Biomedica Revista del Instituto Nacional de Salud"},{"key":"2450_CR55","doi-asserted-by":"publisher","first-page":"09","DOI":"10.18233\/APM36No1pp9-17","volume":"36","author":"MO Jim\u00e9nez-P\u00e9rez","year":"2015","unstructured":"Jim\u00e9nez-P\u00e9rez MO, G\u00f3mez-Garza G, Ruiz-Garc\u00eda M, Fern\u00e1ndez-Lainez C, Ibarra-Gonz\u00e1lez I, Vela-Amieva M. Resonancia magn\u00e9tica nuclear de enc\u00e9falo en pacientes con fenilcetonuria diagnosticada tard\u00edamente. Acta Pediatr de Mex. 2015;36:09\u201317.","journal-title":"Acta Pediatr de Mex"},{"key":"2450_CR56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jped.2014.06.006","volume":"91","author":"VC Kanufre","year":"2015","unstructured":"Kanufre VC, Soares RDL, Alves MRA, Aguiar MJB, Starling ALP, Norton RC. Metabolic syndrome in children and adolescents with phenylketonuria. J Pediat. 2015;91:98\u2013103.","journal-title":"J Pediat"},{"issue":"5","key":"2450_CR57","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0021-75572007000600009","volume":"83","author":"VC Kanufre","year":"2007","unstructured":"Kanufre VC, Starling AL, Leao E, Aguiar MJ, Santos JS, Soares RD, et al. Breastfeeding in the treatment of children with phenylketonuria. J Pediat. 2007;83(5):447\u201352.","journal-title":"J Pediat"},{"issue":"4","key":"2450_CR58","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1590\/S2179-64912012000400016","volume":"24","author":"DAC Lam\u00f4nica","year":"2012","unstructured":"Lam\u00f4nica DAC, Stump MV, Pedro KP, Rolim-Liporacci MC, Caldeira ACGC, Anast\u00e1cio-Pessan FL, et al. Acompanhamento do aleitamento materno no tratamento de crian\u00e7as com fenilceton\u00faria. J Soc Bras Fonoaudiol. 2012;24(4):3816\u20139.","journal-title":"J Soc Bras Fonoaudiol"},{"key":"2450_CR59","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1590\/1982-0216201515313","volume":"17","author":"DAC Lam\u00f4nica","year":"2015","unstructured":"Lam\u00f4nica DAC, Gej\u00e3o MG, Anast\u00e1cio-Pessan FL. Fenilceton\u00faria e habilidades de leitura e escrita. Revista CEFAC. 2015;17:143\u201350.","journal-title":"Revista CEFAC"},{"issue":"1","key":"2450_CR60","first-page":"5","volume":"47","author":"A Mahfoud","year":"2008","unstructured":"Mahfoud A, de Lucca M, Dom\u00ednguez CL, Arias I, Casique L, Araujo K, et al. Clinical findings and mutational spectrum in Venezuelan patients with delayed diagnosis of phenylketonuria. Rev Neurol. 2008;47(1):5\u201310.","journal-title":"Rev Neurol"},{"key":"2450_CR61","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1590\/S0004-282X2004000300018","volume":"62","author":"LF Malloy-Diniz","year":"2004","unstructured":"Malloy-Diniz LF, Cardoso-Martins C, Carneiro KC, Cerqueira MMM, Ferreira APA, Aguiar MJB, et al. Fun\u00e7\u00f5es executivas em crian\u00e7as fenilceton\u00faricas: varia\u00e7\u00f5es em rela\u00e7\u00e3o ao n\u00edvel de fenilalanina. Arq Neuropsiquiatr. 2004;62:473\u20139.","journal-title":"Arq Neuropsiquiatr"},{"key":"2450_CR62","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1590\/S1516-80342010000300012","volume":"15","author":"PC Mancini","year":"2010","unstructured":"Mancini PC, Starling ALP, Penna LM, Ramos CAV, Ferreira MIO, I\u00f3rio MCM. Achados audiol\u00f3gicos em crian\u00e7as com fenilceton\u00faria. Revi Soc Bras Fonoaudiol. 2010;15:383\u20139.","journal-title":"Revi Soc Bras Fonoaudiol"},{"issue":"1","key":"2450_CR63","first-page":"202","volume":"13","author":"M Mari\u00f1o","year":"2000","unstructured":"Mari\u00f1o M, Zarzalejo Z. Tratamiento nutricional de um ni\u00f1o com fenilcetonuria de diagn\u00f3stico neo natal. Estudio de caso An Venez Nutr. 2000;13(1):202\u20139.","journal-title":"Estudio de caso An Venez Nutr"},{"issue":"1","key":"2450_CR64","doi-asserted-by":"publisher","first-page":"97","DOI":"10.12662\/2317-3076jhbs.v7i1.2170.p97-100.2019","volume":"7","author":"RSB Menezes","year":"2019","unstructured":"Menezes RSB, Ribeiro EM, Coelho FMS, Nogueira HBR. Fenilceton\u00faria associada \u00e0 alergia \u00e0 prote\u00edna do leite de vaca. J Health Biol Sci. 2019;7(1):97\u2013100.","journal-title":"J Health Biol Sci"},{"key":"2450_CR65","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1590\/S1415-52732006000300009","volume":"19","author":"LTB Monteiro","year":"2006","unstructured":"Monteiro LTB, C\u00e2ndido LMB. Fenilceton\u00faria no Brasil: evolu\u00e7\u00e3o e casos. Rev Nutr. 2006;19:381\u20137.","journal-title":"Rev Nutr"},{"issue":"3","key":"2450_CR66","first-page":"225","volume":"30","author":"T Nalin","year":"2010","unstructured":"Nalin T, Perry IDS, Refosco LF, Netto CBO, Souza CFM. Fenilceton\u00faria no sistema \u00fanico de sa\u00fade: avalia\u00e7\u00e3o de ades\u00e3o ao tratamento em um centro de atendimento do Rio Grande do Sul. Rev HCPA. 2010;30(3):225\u201332.","journal-title":"Rev HCPA"},{"key":"2450_CR67","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20176709","author":"E Vieira Neto","year":"2018","unstructured":"Vieira Neto E, Filho HSM, Monteiro CB, Carvalho LM, Tonon T, Vanz AP, et al. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients. Braz J Med Biol Res. 2018. https:\/\/doi.org\/10.1590\/1414-431x20176709.","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"2450_CR68","first-page":"320","volume":"85","author":"OA Paneque","year":"2013","unstructured":"Paneque OA, Chac\u00f3n GG, Galcer\u00e1n TZ, Pe\u00f1a DYV, Ram\u00edrez RM, Roca TZO. Evaluaci\u00f3n del estado de salud en pacientes con fenilceton\u00faria. Rev Cubana Pediatr. 2013;85(3):320\u20139.","journal-title":"Rev Cubana Pediatr"},{"issue":"Supl 2","key":"2450_CR69","first-page":"S31","volume":"26","author":"DE Schmidt","year":"2016","unstructured":"Schmidt DE, Norton RC, Starling ALP, Rodrigues VM, Aguiar MJB, Kanufre VC, et al. Defici\u00eancia de vitamina B12 e fenilceton\u00faria. Rev Med Minas Gerais. 2016;26(Supl 2):S31\u20134.","journal-title":"Rev Med Minas Gerais"},{"issue":"1","key":"2450_CR70","first-page":"13","volume":"14","author":"LF Silva","year":"2016","unstructured":"Silva LF, Rodrigues GRB, Cavalcante RH, Silva JAC. Fenilceton\u00faria: perfil e abandono de tratamento em centro de refer\u00eancia no Par\u00e1. Rev Soc Bras Clin Med. 2016;14(1):13\u20137.","journal-title":"Rev Soc Bras Clin Med"},{"key":"2450_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2021.04.009","author":"AM Silveira","year":"2021","unstructured":"Silveira AM, Lima PL, Alves MRA, Soares RDL, Kanufre VC, Rodrigues VM, et al. Overweight\/obesity in adolescents with phenylketonuria: Protective and predisposing factors. J Pediatr. 2021. https:\/\/doi.org\/10.1016\/j.jped.2021.04.009.","journal-title":"J Pediatr"},{"issue":"1","key":"2450_CR72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jocd.2017.02.001","volume":"21","author":"NYY Tanaka","year":"2018","unstructured":"Tanaka NYY, Turcato MF, Nicoletti CF, Nonino CB, Martins LD, Iannetta O, et al. Effects of short-term calcium supplementation in children and adolescents with phenylketonuria. J Clin Densitom. 2018;21(1):48\u201353.","journal-title":"J Clin Densitom"},{"issue":"4","key":"2450_CR73","doi-asserted-by":"publisher","first-page":"108","DOI":"10.14740\/jem581","volume":"9","author":"T Tonon","year":"2019","unstructured":"Tonon T, Martinez C, Poloni S, Nalin T, MacDonald A, Schwartz IVD. Food Neophobia in Patients With Phenylketonuria. J Endocrino Metab. 2019;9(4):108\u201312.","journal-title":"J Endocrino Metab"},{"key":"2450_CR74","first-page":"316","volume":"22","author":"MB Urbanes","year":"2006","unstructured":"Urbanes MB, Alvear C, Moreniz C, Alayon AN, Su\u00e1rez A. Epileptic encephalopathy by phenylcetonuria. Acta Neurol Colomb. 2006;22:316\u201322.","journal-title":"Acta Neurol Colomb"},{"key":"2450_CR75","unstructured":"Brandalize SRC. Avalia\u00e7\u00e3o dos resultados do programa de preven\u00e7\u00e3o e promo\u00e7\u00e3o da sa\u00fade de fenilceton\u00faricos do estado do Paran\u00e1: condi\u00e7\u00e3o motora dos portadores de fenilceton\u00faria com diagn\u00f3stico precoce: Universidade Estadual de Ponta Grossa \u2013 Paran\u00e1; 2002."},{"key":"2450_CR76","unstructured":"Camatta GC. Influ\u00eancia do consumo proteico, da pr\u00e1tica de atividade f\u00edsica, do controle metab\u00f3lico, do est\u00e1gio de matura\u00e7\u00e3o sexual e do IMC no percentual de gordura corporal de adolescentes fenilceton\u00faricos: Universidade Federal de Minas Gerais \u2013 Minas Gerais; 2017."},{"key":"2450_CR77","unstructured":"Castro IPS. Avalia\u00e7\u00e3o da intelig\u00eancia de pacientes com fenilceton\u00faria atendidos pelo programa de triagem neonatal de Minas Gerais: Universidade Federal de Minas Gerais \u2013 Minas Gerais; 2008."},{"key":"2450_CR78","unstructured":"Silva FGS. Preval\u00eancia de transtorno de d\u00e9ficit de aten\u00e7\u00e3o e hiperatividade e outras altera\u00e7\u00f5es neurol\u00f3gicas em fenilceton\u00faricos de um centro do sul do pa\u00eds: Universidade Federal do Rio Grande do Sul \u2013 Rio Grande do Sul; 2018."},{"key":"2450_CR79","unstructured":"Teruya KI. Fatores percebidos pelos pacientes como barreiras a ades\u00e3o ao tratamento de fenilceton\u00faria no Brasil: Universidade Federal do Rio Grande do Sul \u2013 Rio Grande do Sul; 2019."},{"key":"2450_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2020.100595","volume":"23","author":"GC Camatta","year":"2020","unstructured":"Camatta GC, Kanufre VC, Alves MRA, Soares RDL, Norton RC, de Aguiar MJB, et al. Body fat percentage in adolescents with phenylketonuria and associated factors. Mol Genet Metab Rep. 2020;23: 100595.","journal-title":"Mol Genet Metab Rep"},{"issue":"4","key":"2450_CR81","first-page":"353","volume":"88","author":"IPS Castro","year":"2012","unstructured":"Castro IPS, Borges JM, Chagas HA, Tiburcio J, Starling AL, Aguiar MJ. Relationships between phenylalanine levels, intelligence and socioeconomic status of patients with phenylketonuria. J Pediatr. 2012;88(4):353\u20136.","journal-title":"J Pediatr"},{"issue":"1","key":"2450_CR82","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41687-020-00194-w","volume":"4","author":"KI Teruya","year":"2020","unstructured":"Teruya KI, Remor E, Schwartz IVD. Development of an inventory to assess perceived barriers related to PKU treatment. J Patient Rep Outcomes. 2020;4(1):29.","journal-title":"J Patient Rep Outcomes"},{"issue":"1","key":"2450_CR83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2326409815579861","volume":"3","author":"TA Vieira","year":"2015","unstructured":"Vieira TA, Nalin T, Krug BC, Bittar CM, Oliveira Netto CB, Schwartz IVD. Adherence to treatment of phenylketonuria: a study in Southern Brazilian Patients. J Inborn Errors Metab Screen. 2015;3:1-7. https:\/\/doi.org\/10.1177\/2326409815579861","journal-title":"J Inborn Errors Metab Screen"},{"issue":"1","key":"2450_CR84","first-page":"87","volume":"4","author":"IRG Queiroz","year":"2015","unstructured":"Queiroz IRG, Pond\u00e9 MP. Percep\u00e7\u00e3o de pais\/cuidados de indiv\u00edduos com fenilceton\u00faria, com e sem autismo, acompanhados em servi\u00e7o de refer\u00eancia em triagem neonatal. Rev Psicol Divers Sa\u00fade. 2015;4(1):87\u201395.","journal-title":"Rev Psicol Divers Sa\u00fade"},{"key":"2450_CR85","first-page":"191","volume":"65","author":"A S\u00e1nchez-Pe\u00f1a","year":"2008","unstructured":"S\u00e1nchez-Pe\u00f1a A, Mart\u00ednez-de Villarreal L, Arteaga-Alcaraz G, Torres-Sep\u00falveda R, Marroqu\u00edn-Escamilla AR, Abrego-Moya V, et al. Secuelas neurol\u00f3gicas en tres pacientes con fenilcetonuria cl\u00e1sica diagnosticada tard\u00edamente. Bol Med Hosp Infant Mex. 2008;65:191\u20135.","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"2A","key":"2450_CR86","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1590\/S0004-282X2007000200003","volume":"65","author":"CE Steiner","year":"2007","unstructured":"Steiner CE, Acosta AX, Guerreiro MM, Marques-de-Faria AP. Genotype and natural history in unrelated individuals with phenylketonuria and autistic behavior. Arq Neuropsiquiatr. 2007;65(2A):202\u20135.","journal-title":"Arq Neuropsiquiatr"},{"key":"2450_CR87","unstructured":"Valle MG, Enacan R, Mendez V, Prieto L, Pardo-Campos ML, Chiesa A. PKU Clinical Experience. 11th Congress of the Latin American Society of Inborn Errors of Metabolism and Neonatal Screening; 12\u201315 May 2019; Buenos Aires, Argentina: J Inborn Errors Metab Screen; 2019."},{"key":"2450_CR88","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1590\/S0034-89102004000200021","volume":"38","author":"SRC Brandalize","year":"2004","unstructured":"Brandalize SRC, Czeresnia D. Avalia\u00e7\u00e3o do programa de preven\u00e7\u00e3o e promo\u00e7\u00e3o da sa\u00fade de fenilceton\u00faricos. Rev Sa\u00fade P\u00fablica. 2004;38:300\u20136.","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"2450_CR89","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4067\/S0717-75182010000100011","volume":"37","author":"OP Peredo","year":"2010","unstructured":"Peredo OP, Raimann BE, Cataldo GX, Gallardo GS, Cornejo EV. Sindrome de fenilquetonuria materna, un nuevo desaf\u00edo para Chile. Rev Chil Nutr. 2010;37:111\u20137.","journal-title":"Rev Chil Nutr"},{"key":"2450_CR90","first-page":"28","volume":"85","author":"M Rasner","year":"2014","unstructured":"Rasner M, Vomero A, Varacchi C, Peluffo G, Giachetto G, Kanopa V. Fenilcetonuria: descripci\u00f3n de un caso cl\u00ednico. Arch Pediatr Urug. 2014;85:28\u201333.","journal-title":"Arch Pediatr Urug"},{"key":"2450_CR91","unstructured":"Silva LF. Avalia\u00e7\u00e3o dos n\u00edveis de marcadores de neurodegenera\u00e7\u00e3o em plasma de pacientes fenilceton\u00faricos: Universidade do Extremo Sul Catarinense \u2013 Crici\u00fama; 2016."},{"issue":"1","key":"2450_CR92","first-page":"16","volume":"19","author":"YP Patricio","year":"2018","unstructured":"Patricio YP, Maritza M. Fenilcetonuria em um neonato de 29 semanas de edad gestacional: reporte de caso clinico. Rev Ecuat Pediatr. 2018;19(1):16\u20137.","journal-title":"Rev Ecuat Pediatr"},{"key":"2450_CR93","first-page":"290","volume":"65","author":"L Pereda-Torales","year":"2008","unstructured":"Pereda-Torales L, Calc\u00e1neo-Garc\u00eda JA, Enr\u00edquez-Torrecilla R, Badillo-B\u00e1ez EM, Soler-Huerta E. Identificaci\u00f3n de un caso de fenilcetonuria a trav\u00e9s del tamizaje neonatal. Bol Med Hosp Infant Mex. 2008;65:290\u20136.","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"2","key":"2450_CR94","first-page":"187","volume":"24","author":"MP Santos","year":"2013","unstructured":"Santos MP, Haack A. Fenilceton\u00faria em escolar: um relato de caso. Com Ci\u00eancias Sa\u00fade. 2013;24(2):187\u2013200.","journal-title":"Com Ci\u00eancias Sa\u00fade"},{"key":"2450_CR95","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1590\/S1415-52732011000600007","volume":"24","author":"JS Santos","year":"2011","unstructured":"Santos JS, Aguiar MJB, Starling ALP, Kanufre VC, Tib\u00farcioz JD, Lima MOB. Consumo alimentar de lactentes com fenilceton\u00faria em uso de aleitamento materno. Rev de Nutr. 2011;24:863\u201372.","journal-title":"Rev de Nutr"},{"issue":"2","key":"2450_CR96","first-page":"73","volume":"45","author":"J Andere","year":"1988","unstructured":"Andere J, Mota de Avelar-Alchorne M, Schmidt BJ, Schwery-Michalany N. Classic phenylketonuria: dermatological and histopathological aspects in 35 patients. Bol Med Hosp Infant Mex. 1988;45(2):73\u20138.","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"1","key":"2450_CR97","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4322\/2357-9730.88599","volume":"39","author":"RS P\u00e9rsico","year":"2019","unstructured":"P\u00e9rsico RS, Nalin T, L.F. R, Vairo FP, Souza CFM. An\u00e1lise da densidade mineral \u00f3ssea em pacientes com fenilceton\u00faria e sua correla\u00e7\u00e3o com par\u00e2metros nutricionais. Clin Biomed Res. 2019;39(1):24\u201331.","journal-title":"Clin Biomed Res"},{"key":"2450_CR98","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1590\/S0104-56872010000300031","volume":"22","author":"GK Silva","year":"2010","unstructured":"Silva GK, Lam\u00f4nica DAC. Desempenho de crian\u00e7as com fenilceton\u00faria no Teste de Screening de Desenvolvimento Denver - II. Pro-Fono. 2010;22:345\u201350.","journal-title":"Pro-Fono"},{"key":"2450_CR99","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1590\/S1516-80342012000300003","volume":"17","author":"PS Ribeiro","year":"2012","unstructured":"Ribeiro PS, Torres TL, Starling ALP, I\u00f3rio MCM, Mancini PC. Crian\u00e7as com fenilceton\u00faria: avalia\u00e7\u00e3o audiol\u00f3gica b\u00e1sica e supress\u00e3o das otoemiss\u00f5es. Rev Soc Bras Fonoaudiol. 2012;17:248\u201353.","journal-title":"Rev Soc Bras Fonoaudiol"},{"issue":"1","key":"2450_CR100","first-page":"1","volume":"18","author":"C Russo-Estavillo","year":"2018","unstructured":"Russo-Estavillo C, V\u00e1squez-Avelar S, Real-Guerrero J, Belmont-Mart\u00ednez L, Escoto-Delgadillo M, et al. High frequency of severe phenylketonuria in Jalisco, Mexico. Int J Genet. 2018;18(1):1\u20136.","journal-title":"Int J Genet"},{"key":"2450_CR101","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1590\/S0004-27302009000400010","volume":"53","author":"I Stranieri","year":"2009","unstructured":"Stranieri I, Takano OA. Avalia\u00e7\u00e3o do Servi\u00e7o de Refer\u00eancia em Triagem Neonatal para hipotireoidismo cong\u00eanito e fenilceton\u00faria no Estado de Mato Grosso. Brasil Arq Bras Endocrinol Metabol. 2009;53:446\u201352.","journal-title":"Brasil Arq Bras Endocrinol Metabol"},{"issue":"2","key":"2450_CR102","first-page":"337","volume":"57","author":"LR Desviat","year":"1995","unstructured":"Desviat LR, P\u00e9rez B, De Lucca M, Cornejo V, Schmidt B, Ugarte M. Evidence in Latin America of recurrence of V388M, a phenylketonuria mutation with high in vitro residual activity. Am J Med Genet A. 1995;57(2):337\u201342.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"2450_CR103","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3390\/nu11092070","volume":"11","author":"F Ilgaz","year":"2019","unstructured":"Ilgaz F, Pinto A, Gokmen-Ozel H, Rocha JC, van Dam E, Ahring K, et al. Long-term growth in phenylketonuria: a systematic review and meta-analysis. Nutrients. 2019;11(9):2070.","journal-title":"Nutrients"},{"issue":"7","key":"2450_CR104","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.3390\/nu12072154","volume":"12","author":"MJ de Castro","year":"2020","unstructured":"de Castro MJ, de Lamas C, Sanchez-Pintos P, Gonzalez-Lamuno D, Couce ML. Bone status in patients with phenylketonuria: a systematic review. Nutrients. 2020;12(7):2154.","journal-title":"Nutrients"},{"issue":"Suppl 3","key":"2450_CR105","doi-asserted-by":"publisher","first-page":"S363","DOI":"10.1007\/s10545-010-9189-0","volume":"33","author":"S Lage","year":"2010","unstructured":"Lage S, Bueno M, Andrade F, Prieto JA, Delgado C, Legarda M, et al. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density. J Inherit Metab Dis. 2010;33(Suppl 3):S363\u201371.","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"2450_CR106","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1651-2227.1999.tb01049.x","volume":"88","author":"J Zeman","year":"1999","unstructured":"Zeman J, Bayer M, Step\u00e1n J. Bone mineral density in patients with phenylketonuria. Acta Paediatr. 1999;88(12):1348\u201351.","journal-title":"Acta Paediatr"},{"issue":"3","key":"2450_CR107","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10545-011-9412-7","volume":"35","author":"AB Mendes","year":"2012","unstructured":"Mendes AB, Martins FF, Cruz WM, da Silva LE, Abadesso CB, Boaventura GT. Bone development in children and adolescents with PKU. J Inherit Metab Dis. 2012;35(3):425\u201330.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2450_CR108","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s10545-007-0462-9","volume":"30","author":"D Modan-Moses","year":"2007","unstructured":"Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R, et al. Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis. 2007;30(2):202\u20138.","journal-title":"J Inherit Metab Dis"},{"key":"2450_CR109","unstructured":"Coakley KE, Douglas TD, Singh RH. Using predictive modeling to estimate bone mineral density in children and adults with phenylketonuria. Interdisciplinary symposium on osteoporosis 2013 - Patient-centered care: Developing successful bone health teams, ISO 2013 Chicago, IL United States. 2013. p. S431-S2."},{"key":"2450_CR110","doi-asserted-by":"publisher","DOI":"10.1590\/1984-0462\/2020\/38\/2018201","volume":"38","author":"BDS Sena","year":"2020","unstructured":"Sena BDS, Andrade MIS, Silva A, Dourado KF, Silva ALF. Overweight and associated factors in children and adolescents with phenylketonuria: a systematic review. Rev Paul Pediatr. 2020;38: e2018201.","journal-title":"Rev Paul Pediatr"},{"issue":"4","key":"2450_CR111","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/87565641.2016.1243109","volume":"41","author":"DA Bilder","year":"2016","unstructured":"Bilder DA, Noel JK, Baker ER, Irish W, Chen Y, Merilainen MJ, et al. Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria. Dev Neuropsychol. 2016;41(4):245\u201360.","journal-title":"Dev Neuropsychol"},{"issue":"2","key":"2450_CR112","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jimd.12065","volume":"42","author":"AP Burlina","year":"2019","unstructured":"Burlina AP, Lachmann RH, Manara R, Cazzorla C, Celato A, van Spronsen FJ, et al. The neurological and psychological phenotype of adult patients with early-treated phenylketonuria: a systematic review. J Inherit Metab Dis. 2019;42(2):209\u201319.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2450_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2017.03.002","volume":"121","author":"DA Bilder","year":"2017","unstructured":"Bilder DA, Kobori JA, Cohen-Pfeffer JL, Johnson EM, Jurecki ER, Grant ML. Neuropsychiatric comorbidities in adults with phenylketonuria: a retrospective cohort study. Mol Genet Metab. 2017;121(1):1\u20138.","journal-title":"Mol Genet Metab"},{"key":"2450_CR114","doi-asserted-by":"publisher","first-page":"100764","DOI":"10.1016\/j.ymgmr.2021.100764","volume":"27","author":"F Trefz","year":"2021","unstructured":"Trefz F, Muntau AC, Schneider KM, Altevers J, Jacob C, Braun S, Greiner W, Jha A, Jain M, Alvarez I, Lane P, Zeiss C, Rutsch F. Health economic burden of patients with phenylketonuria (PKU) - A retrospective study of German health insurance claims data. Mol Genet Metab Rep. 2021;27:100764. https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100764.","journal-title":"Genet Metab Rep"},{"issue":"1","key":"2450_CR115","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jclinepi.2013.08.003","volume":"67","author":"JJ Gagnier","year":"2014","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol. 2014;67(1):46\u201351.","journal-title":"J Clin Epidemiol"},{"key":"2450_CR116","unstructured":"Guyatt GH, Busse JW. Modification of Ottawa-Newcastle to assess risk of bias in nonrandomized trials [Available from: http:\/\/distillercer.com\/resources\/]."},{"issue":"7414","key":"2450_CR117","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"2450_CR118","unstructured":"The Nordic Cochrane Centre TCC. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. 2011."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02450-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02450-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T20:07:55Z","timestamp":1668629275000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02450-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2450"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02450-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The other authors have declared no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}